Shares of AngioDynamics (ANGO) have gained 0.1% over the past four weeks to close the last trading session at $10.06, but there could still be a solid upside left in the stock if short-term price ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s ...

Well, good morning, everyone. Thank you for joining us. I'm Danielle Antalffy, the U.S. MedTech analyst here at UBS. And happy to kick off our Annual Healthcare Conference with the AngioDynamics team.

Another mixed quarter in Q3 FY'22 for AngioDynamics, despite strengths in its international markets. Management revised guidance higher, but this may widen the operating loss as well, in my view.